Skip to main content

Table 2 Expression of surface antigens on peripheral blood monocytes in the studied women

From: Surface antigen expression on peripheral blood monocytes in women with gynecologic malignancies

Laboratory Data

Endometrial Cancer (N = 42)

Cervical Cancer (N = 13)

Ovarian Cancer (N = 14)

Group I (N = 20)

Group II (N = 23)

CD11a (%)

99.98 ± 0.06;

99.94 ± 0.21;

99.44 ± 1.94;

99.99 ± 0.05;

99.96 ± 0.09;

100.00

100.00

100.00

100.00

100.00

(99.74-100.00)

(99.23-100.00)

(92.72-100.00)

(99.79-100.00)

(99.59 -100.00)

CD11b (%)

99.72 ± 0.73;

99.35 ± 1.60;

99.87 ± 0.16;

99.72 ± 0.45;

99.91 ± 0.16;

99.87 *

99.86 *

99.93

99.93 *

100.00

(95.28-100.00)

(94.08-100.00)

(99.40-100.00)

(98.07-100.00)

(99.47-100.00)

CD11c (%)

99.54 ± 1.36;

97.62 ± 6.74;

98.27 ± 5.87;

99.77 ± 0.37;

99.40 ± 2.37;

100.00

99.93

100.00

99.96

100.00

(92.49-100.00)

75.38-100.00)

(77.93-100.00)

(98.91-100.00)

(88.63-100.00)

CD16 (%)

17.86 ± 22.51;

11.99 ± 18.09;

26.19 ± 31.96;

16.99 ± 26.21;

10.64 ± 4.95;

7.19

6.16 *

8.84

6.37 **

9.55

(2.39-83.80)

(1.23-69.87)

(4.24-91.53)

(2.78-85.20)

(5.23-28.30)

CD54 (%)

83.89 ± 16.44;

87.27 ± 12.32;

89.86 ± 11.94;

92.40 ± 9.16;

63.82 ± 15.21;

88.46 ***

91.46 ***

94.57 ***

97.00 ***

65.20

(27.75-100.00)

(68.40-100.00)

(63.90-100.00)

(69.87-100.00)

(21.61-91.75)

CD62L (%)

97.64 ± 2.06;

96.51 ± 4.99;

98.80 ± 1.51;

93.69 ± 9.74;

96.56 ± 2.83;

98.35

97.85

99.18 ***

98.23

97.01

(93.00-100.00)

(80.38-99.54)

(94.74-100.00)

(67.94-99.86)

(85.40-99.70)

CD64 (%)

95.57 ± 9.06;

93.38 ± 7.42;

97.88 ± 4.67;

96.80 ± 5.22;

99.39 ± 1.19;

99.16 ***

96.30 **

99.65

99.59 *

99.91

(47.60-100.00)

(76.60-100.00)

(82.13-100.00)

(81.93-100.00)

(95.15-100.00)

HLA-DR (%)

80.94 ± 15.85;

68.50 ± 25.66;

73.98 ± 16.60;

70.22 ± 24.76;

94.98 ± 5.66;

85.80 ***

76.60 ***

73.35 ***

79.70 ***

96.10

(33.13-99.71)

(18.50-95.83)

(27.65-95.21)

(17.33-99.37)

(73.48-99.63)

  1. Group I - women operated but had no malignancy in postoperative histopathologic examination, Group II - healthy women. SD - standard deviation, CD - cluster of differentiation molecule, HLA-DR - membrane receptor: Human leukocyte antigen-DR (product of hla-dr locus). Data are presented as: mean ± 1 SD, median (minimum-maximum). Asterisks indicate statistically significant differences in Mann–Whitney U test: * - p < 0.05; ** - p < 0.01; *** - p < 0.001, in comparison to Group II.